What Is CJC-1295?

Category: Peptide

A synthetic analog of growth hormone releasing hormone (GHRH). Available in two forms: with DAC (long-acting, dosed weekly) and without DAC/Mod GRF 1-29 (short-acting, dosed 2-3x daily).

Detailed Explanation

CJC-1295 is a synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH). It comes in two forms: CJC-1295 with DAC (Drug Affinity Complex), which has an extended half-life of 6-8 days allowing weekly dosing, and CJC-1295 without DAC (also known as Mod GRF 1-29), which has a short half-life of about 30 minutes requiring multiple daily doses. Both versions stimulate the pituitary gland to release growth hormone in a pulsatile manner.

Practical Context

CJC-1295 without DAC (Mod GRF 1-29) is most commonly combined with a GHRP like Ipamorelin for synergistic growth hormone release. This combination is considered the gold standard for GH optimization. The no-DAC version provides a more natural, pulsatile GH release pattern, while the DAC version creates more sustained elevation. Both should be taken on an empty stomach for maximum effect.

Frequently Asked Questions

Should I use CJC-1295 with or without DAC?

Without DAC (Mod GRF 1-29) provides more natural pulsatile GH release and is the preferred choice for most researchers. With DAC provides convenience of less frequent dosing but creates more sustained (less natural) GH elevation.

Why combine CJC-1295 with Ipamorelin?

CJC-1295 (GHRH) and Ipamorelin (GHRP) work through different but complementary pathways. Together, they produce a stronger GH pulse than either alone, similar to pressing the gas pedal and releasing the brake simultaneously.

Related Peptides

Related Terms

More Peptide Terms

Full Glossary | Dosage Calculator | Browse Peptides